A series of N-biarylalkyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-ones were prepared and evaluated for biological activity at opioid (mu, delta, kappa) and opioid receptor like-1 (ORL-1) G-protein coupled receptors. Substitution on the biaryl moiety produced enhanced affinity for the mu-opioid receptor.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/157340605774598207 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!